[Treatment of paroxysmal nocturnal hemoglobinuria with danazol].

In: [Rinsho ketsueki] The Japanese journal of clinical hematology · 1990 · vol. 31(9) , pp. 1489–92 · PMID:2246821 · W2418786866
article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed

Abstract

Glucocorticoid and androgen therapy have been used with moderate success in paroxysmal nocturnal hemoglobinuria (PNH). However, both are poorly tolerated, especially in women, although the side effects of glucocorticoid can be diminished by alternate day therapy. We have treated two patients with PNH with danazol. One of patient is man, 64 years old age with stomach cancer, and the other patient is 34-year-old man. Their disease has existed for 6-14 years. They required many blood transfusions, their hemoglobins ranging between 7.1 and 9.9 grams per deciliter. When treated with danazol by mouth, the hemoglobin level increased approximately 2 to 5 grams in each patient within 3 week, and clinical hemoglobinuria improved. None of the patients has had any side effects.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

openalex
last seen: 2026-05-10T10:55:00.350230+00:00
License: CC0 · commercial use OK